Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
COVID-19 in donation and transplant68
52
47
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-238
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations32
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician26
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León25
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project24
Cefiderocol24
Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection22
Highlights in HIV 2022-202419
De la rinolicuorrea al 16S: meningitis por Streptococcus salivarius19
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker18
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain17
Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)16
Is Propionimicrobium lymphophilum a new urinary tract infection cause?16
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences16
0.2378568649292